While these results are in agreement with previous studies proposing that potent STING activation in T cells triggers cell death,24 26 they also indicate that milder STING activation can enhance T-cell effector properties without killing them, a finding that will be of importance as this pathway is targeted for cancer therapy development. The gene discussed is STING1; the disease is cancer.